Biomarkers and Molecular Mechanisms in Renal Diseases

Biomarkers and Molecular Mechanisms in Renal Diseases are pivotal for understanding kidney pathophysiology and improving diagnosis and treatment. Biomarkers such as albuminuria, creatinine levels, and novel markers like kidney injury molecule-1 (KIM-1) help detect early kidney damage, assess disease progression, and predict patient outcomes. Understanding the molecular mechanisms, including inflammatory pathways, fibrosis, and genetic factors, aids in the development of targeted therapies for conditions like glomerulonephritis, diabetic nephropathy, and acute kidney injury. Ongoing research aims to identify new biomarkers for personalized medicine and improve therapeutic approaches in nephrology.

 

    Related Conference of Biomarkers and Molecular Mechanisms in Renal Diseases

    August 28-29, 2025

    10th World Kidney Congress

    London, UK
    November 03-04, 2025

    29th European Nephrology Conference

    Rome, Italy
    December 10-11, 2025

    12th World Congress on Epidemiology & Public Health

    Amsterdam, Netherlands
    March 09-10, 2026

    17th Nephrology,Renal Medicine & Renal Care

    Dubai, UAE
    March 26-27, 2026

    22nd World Nephrology Conference

    Amsterdam, Netherlands
    June 29-30, 2026

    18th World Nephrology Summit

    Aix-en-Provence, France

    Biomarkers and Molecular Mechanisms in Renal Diseases Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in